NCT00772122View on ClinicalTrials.gov

Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Habitual Abortion
Interventions
DRUG

G-CSF

daily sub-cutaneous administration of the recombinant G-CSF, at a dosage of 1 microgram (100000 IU)/kg/day from the 6th day after ovulation till the occurrence of menstruation or to the end of the 9th week of gestation.

DRUG

saline solution

daily sub-cutaneous administration of saline solution 0.2ml from the 6th day after the ovulation till to the recurrence of menstrual loss or to the end of the 9th week.

Trial Locations (1)

00198

CERM, Rome

All Listed Sponsors
lead

University of Florence

OTHER

NCT00772122 - Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage | Biotech Hunter | Biotech Hunter